Reporting CMC Post-Approval Changes

Playback speed

×

Share post

Share post at current time

Share from 0:00

0:00

/

0:00

Preview

Reporting CMC Post-Approval Changes, Proactively Addressing the Root Causes of Medical Device Recalls + Warning Letter Breakdown

We explore a new guidance clarifying post-approval changes to disposable materials, examine new research into the root causes of device recalls, and break down a validation Warning Letter.

The FDA Group

Dec 01, 2022

∙ Paid

Share

Welcome to Insider issue #8.

And welcome to the 91 new life science professionals who joined last month.

Today we’re looking at a new FDA draft guidance on creating and maintaining pharma Risk Manageme…

The full video is for paid subscribers

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts

The FDA Group's Insider Newsletter

Reporting CMC Post-Approval Changes, Proactively Addressing the Root Causes of Medical Device Recalls + Warning Letter Breakdown

The full video is for paid subscribers